• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Enanta Pharmaceutica (NQ: ENTA )

    11.84 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 11.84
    Bid (Size) 9.510 (1)
    Ask (Size) 18.94 (2)
    Prev. Close 11.84
    Today's Range 11.84 - 11.84
    52wk Range 8.080 - 17.80
    Shares Outstanding 21,055,392
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Enanta Pharmaceuticals to Participate in Investor Conferences in September
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024
    ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +17.46%
    +17.46%
    1 Month
    -8.92%
    -8.92%
    3 Month
    -5.58%
    -5.58%
    6 Month
    -24.68%
    -24.68%
    1 Year
    -2.39%
    -2.39%

    More News

    Read More
    Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Recap: Enanta Pharma Q1 Earnings
    Via Benzinga
    Earnings Scheduled For February 7, 2024
    Via Benzinga
    Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Earnings Preview For Enanta Pharma
    Via Benzinga
    Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) Near the Top of Equities by Percentage Gain on 11/21
    Via Investor Brand Network
    What 5 Analyst Ratings Have To Say About Enanta Pharma
    Via Benzinga
    Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Recap: Enanta Pharma Q4 Earnings
    Via Benzinga
    Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.